11,223 Shares in Corteva, Inc. $CTVA Acquired by Avanza Fonder AB

Avanza Fonder AB acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 11,223 shares of the company’s stock, valued at approximately $752,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Appleton Partners Inc. MA acquired a new stake in Corteva in the fourth quarter worth $245,000. S.E.E.D. Planning Group LLC lifted its position in Corteva by 6.9% in the 4th quarter. S.E.E.D. Planning Group LLC now owns 185,508 shares of the company’s stock valued at $12,435,000 after purchasing an additional 11,938 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Corteva by 13.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 172,072 shares of the company’s stock worth $12,154,000 after purchasing an additional 20,572 shares during the last quarter. NorthCrest Asset Manangement LLC increased its stake in shares of Corteva by 3.9% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 143,051 shares of the company’s stock valued at $9,706,000 after purchasing an additional 5,315 shares during the period. Finally, Grove Bank & Trust increased its stake in shares of Corteva by 31.6% in the fourth quarter. Grove Bank & Trust now owns 1,136 shares of the company’s stock valued at $76,000 after purchasing an additional 273 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.14% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CTVA. Mizuho boosted their price objective on Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 17th. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Oppenheimer set a $86.00 price objective on shares of Corteva in a report on Thursday, February 5th. Wolfe Research increased their target price on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Finally, Argus raised shares of Corteva to a “strong-buy” rating in a research note on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $82.90.

Corteva Trading Up 1.8%

Shares of Corteva stock opened at $82.00 on Thursday. The business has a fifty day simple moving average of $75.76 and a 200-day simple moving average of $69.53. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $82.26. The firm has a market cap of $55.05 billion, a price-to-earnings ratio of 51.90, a price-to-earnings-growth ratio of 2.75 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the previous year, the business earned $0.32 earnings per share. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s payout ratio is presently 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.